Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2021

Jul 15, 2021

284_dirs_2021-07-15_6fc5573e-e3a5-4661-bc7c-e9225d76b051.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-07-05

Reporting Person: Klobuchar Michael A (EVP - Chief Strategy Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11064.93 Direct
Common Stock 6.19 Indirect
Common Stock 6.19 Indirect
Common Stock - 401(k) Plan 797.3418 Indirect
Common Stock - 401(k) Plan 641.797 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Unit $ 2022-05-03 Common Stock (773) Direct
Restricted Stock Unit $ 2023-05-01 Common Stock (1732) Direct
Restricted Stock Unit $ 2024-05-04 Common Stock (2657) Direct
Stock Option (Right to Buy) $53.06 2026-05-09 Common Stock (6416) Direct
Stock Option (Right to Buy) $62.07 2027-05-04 Common Stock (9704) Direct
Stock Option (Right to Buy) $56.04 2028-05-03 Common Stock (12447) Direct
Stock Option (Right to Buy) $77.62 2029-05-02 Common Stock (17455) Direct
Stock Option (Right to Buy) $75.36 2030-04-30 Common Stock (20313) Direct
Stock Option (Right to Buy) $73.73 2031-05-03 Common Stock (20603) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through July 5, 2021 in the Merck U.S. Savings Plan, a 401(k) plan.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

F4: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F5: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

F6: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

F7: The option became exercisable in equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.

F8: The option became exercisable in equal installments on 5/5/2018, 5/5/2019 and 5/5/2020.

F9: The option became exercisable in equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

F10: The option vests and becomes exercisable in equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

F11: The option vests and becomes exercisable in equal installments on 5/1/2021, 5/1/2022 and 5/1/2023.

F12: The option vests and becomes exercisable in equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.